Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.

Cell death and differentiation - 1 Nov 2006

Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie P J

Abstract excerpt

Osteosarcoma is the most common primary bone tumour in young adults. Despite improved prognosis, resistance to chemotherapy remains responsible for failure of osteosarcoma treatment. The identification of signals that promote apoptosis may provide clues to develop new therapeutic strategies for chemoresistant osteosarcoma. Here, we show that lipophilic statins (atorvastatin, simvastatin, cerivastatin) markedly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Atorvastatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Morphogenetic Protein 2

Share to Heptanoic Acids

Share to Polyisoprenyl Phosphates

Share to Pyrroles

Share to rhoA GTP-Binding Protein

Share to Simvastatin

Source

Identifiers

PMID: 16470222
DOI: 10.1038/sj.cdd.4401873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.PMID 16470222Read ↗

Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expressionSemantic proximity Read ↗

Lipophilic statins antagonistically alter the major epithelial‐to‐mesenchymal transition signaling pathways in breast cancer stem–like cells via inhibition of the mevalonate pathwaySemantic proximity Read ↗

Statins are potential anticancerous agents (Review)Semantic proximity Read ↗

Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.Semantic proximity Read ↗

In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cellsSemantic proximity Read ↗

Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelateSemantic proximity Read ↗

Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.Semantic proximity Read ↗

Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells.Semantic proximity Read ↗

Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.Semantic proximity Read ↗

Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway.Semantic proximity Read ↗

Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation.Semantic proximity Read ↗

In vitro Molecular Mechanisms of Anticancer Activity of Stevioside in Human Osteosarcoma Cell Lines (Sarcoma Osteogenic)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.